Sarepta Therapeutics | SRPT - Pre Tax Profit

Stock Price
16.60
Daily Change
-0.56 -3.26%
Monthly
-12.08%
Yearly
-77.40%
Q1 Forecast
15.90

Sarepta Therapeutics reported $-407.67M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
Insmed USD -326.93M 41.77M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
Moderna USD -187M 631M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Novavax USD 17.9M 220.94M Dec/2025
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025